JUBLIA

This brand name is authorized in Canada, Hong Kong, United States

Active ingredients

The drug JUBLIA contains one active pharmaceutical ingredient (API):

1 Efinaconazole UNII J82SB7FXWB - EFINACONAZOLE

Efinaconazole is an azole antifungal used for the topical treatment of onychomycosis. Read about Efinaconazole

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
JUBLIA Solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D01AC19		D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC19

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02413388
Country: HK	Department of Health Drug Office	Identifier(s): 66407
Country: US	FDA, National Drug Code	Identifier(s): 0187-5400